Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7355 EUR 2.65% Market Closed
Market Cap: 498.9m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Interest Income Expense Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Interest Income Expense
$1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Interest Income Expense
€2.4m
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Interest Income Expense
-$34.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-36%
argenx SE
XBRU:ARGX
Interest Income Expense
$115m
CAGR 3-Years
N/A
CAGR 5-Years
24%
CAGR 10-Years
104%
Merus NV
NASDAQ:MRUS
Interest Income Expense
-$6.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Interest Income Expense
$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Interest Income Expense?
Interest Income Expense
1m USD

Based on the financial report for Jun 30, 2024, Pharming Group NV's Interest Income Expense amounts to 1m USD.

Back to Top